ANIX Historical PE Ratio Notes

— Anixa Biosciences (ticker symbol ANIX) is a clinical-stage biotechnology company focused on developing immunotherapies & diagnostics for cancer and infectious diseases. Unlike many established firms, Anixa does not generate significant recurring revenue from marketed products, as its programs are primarily in early-stage trials and research. This business model often means negative or negligible earnings, which in turn creates anomalies in the historical price-to-earnings (PE) ratio data you'll encounter. When reviewing historical charts & tables, note that the PE ratio for ANIX is likely to be non-meaningful (negative or extremely high) during most periods, reflecting a lack of consistent profitability rather than investor misjudgment. Analysts & investors often value such development-stage biotech companies based on future growth potential or research milestones, rather than traditional earnings-based metrics. Therefore, ANIX’s historical PE ratios should be interpreted with caution: large swings, gaps, or undefined values typically indicate the company's ongoing investment in R&D and absence of earnings, not operational inefficiency or mismanagement. When researching, consider the fundamental differences between biotech development firms like Anixa and profit-generating businesses, as the PE ratio alone may not capture the value or risks inherent to this kind of company.

On this page we presented the ANIX Historical PE Ratio information for Anixa Biosciences' stock. The average ANIX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ANIX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ANIX historical PE result, against the recent PE: when this page was posted on 9/10/2026, the most recent closing price for ANIX had been 2.75, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ANIX or any other given stock, valuation analysis for ANIX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Anixa Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ANIX. Thanks for visiting, and the next time you need to research ANIX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.